Kristen Marks

4.9k total citations · 1 hit paper
49 papers, 1.1k citations indexed

About

Kristen Marks is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Kristen Marks has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 36 papers in Hepatology and 16 papers in Infectious Diseases. Recurrent topics in Kristen Marks's work include Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis B Virus Studies (17 papers). Kristen Marks is often cited by papers focused on Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis B Virus Studies (17 papers). Kristen Marks collaborates with scholars based in United States, United Kingdom and Qatar. Kristen Marks's co-authors include Andrew H. Talal, Shashi N. Kapadia, Benjamin Eckhardt, Ira M. Jacobson, Roy M. Gulick, Marshall J. Glesby, Pedro Mateu‐Gelabert, Yesenia Aponte-Meléndez, Chunki Fong and Brian R. Edlin and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kristen Marks

46 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

2023 115 citations Erin E. Conners, Lakshmi Panagiotakopoulos et al. PubMed Central profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristen Marks United States	19	676	650	321	118	89	49	1.1k
Patrick Miailhes France	24	995 1.5×	862 1.3×	383 1.2×	61 0.5×	148 1.7×	82	1.4k
Oluwaseun Falade‐Nwulia United States	20	1.1k 1.6×	1.0k 1.6×	393 1.2×	51 0.4×	146 1.6×	75	1.6k
Marcello Piazza Italy	18	432 0.6×	451 0.7×	300 0.9×	119 1.0×	65 0.7×	38	953
Mark Sonderup South Africa	18	715 1.1×	671 1.0×	272 0.8×	39 0.3×	43 0.5×	64	1.1k
David Vlahov United States	7	875 1.3×	803 1.2×	321 1.0×	72 0.6×	42 0.5×	8	1.1k
Mark Danta Australia	20	1.2k 1.8×	1.3k 2.0×	460 1.4×	98 0.8×	38 0.4×	66	1.8k
Anna Maccabruni Italy	16	610 0.9×	505 0.8×	340 1.1×	93 0.8×	66 0.7×	59	1.0k
Caroline Lascoux‐Combe France	22	944 1.4×	764 1.2×	448 1.4×	100 0.8×	55 0.6×	64	1.5k
Amanda Yu Canada	22	1.0k 1.5×	912 1.4×	177 0.6×	50 0.4×	112 1.3×	67	1.3k
Giorgio Antonucci Italy	16	707 1.0×	320 0.5×	502 1.6×	69 0.6×	46 0.5×	29	962

Countries citing papers authored by Kristen Marks

Since Specialization

Citations

This map shows the geographic impact of Kristen Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen Marks more than expected).

Fields of papers citing papers by Kristen Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen Marks. The network helps show where Kristen Marks may publish in the future.

Co-authorship network of co-authors of Kristen Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen Marks. A scholar is included among the top collaborators of Kristen Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen Marks. Kristen Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gispen, Fiona & Kristen Marks. (2025). Update on Vaccination Recommendations for Adults with HIV. Current HIV/AIDS Reports. 22(1). 17–17.

Mateu‐Gelabert, Pedro, Chunki Fong, Shashi N. Kapadia, et al.. (2024). Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model. PLoS ONE. 19(8). e0308102–e0308102. 1 indexed citations

Conners, Erin E., Lakshmi Panagiotakopoulos, Megan G. Hofmeister, et al.. (2023). Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. PubMed Central. 72(1). 1–25. 115 indexed citations breakdown →

Follmann, Dean, Holly Janes, Olive D. Buhule, et al.. (2022). Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial. Annals of Internal Medicine. 175(9). 1258–1265. 69 indexed citations

Kapadia, Shashi N., Benjamin Eckhardt, Jared A. Leff, et al.. (2022). Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial. SHILAP Revista de lepidopterología. 5. 100109–100109. 1 indexed citations

Loo, Angela, et al.. (2021). 958. A Required Infectious Diseases Rotation Improves Antimicrobial Stewardship Knowledge for Internal Medicine Interns. Open Forum Infectious Diseases. 8(Supplement_1). S571–S572.

Aponte-Meléndez, Yesenia, Pedro Mateu‐Gelabert, Chunki Fong, et al.. (2021). The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services. Harm Reduction Journal. 18(1). 118–118. 42 indexed citations

Salvatore, Mirella, et al.. (2020). Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion. Open Forum Infectious Diseases. 7(9). ofaa345–ofaa345. 29 indexed citations

Kapadia, Shashi N. & Kristen Marks. (2018). Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers. Clinical Therapeutics. 40(8). 1234–1245. 32 indexed citations

10.

Kapadia, Shashi N., Carrie D. Johnston, Kristen Marks, Bruce R. Schackman, & Erika G. Martin. (2018). Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity. Journal of Public Health Management and Practice. 25(3). 245–252. 14 indexed citations

11.

Dharan, Nila J., Jacqueline Neuhaus, Juergen Rockstroh, et al.. (2018). Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial. Hepatology. 69(3). 1135–1150. 11 indexed citations

12.

Marks, Kristen, et al.. (2018). Management of hepatitis B and C infections in rheumatologic disease. Best Practice & Research Clinical Rheumatology. 32(6). 848–868. 2 indexed citations

13.

Eckhardt, Benjamin, Marla A. Shu, Courtney McKnight, et al.. (2017). Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention. PLoS ONE. 12(5). e0177341–e0177341. 48 indexed citations

14.

Sherman, Kenneth E., Minhee Kang, Richard K. Sterling, et al.. (2017). Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World Journal of Hepatology. 9(4). 217–217. 3 indexed citations

15.

Mehta, Natasha, et al.. (2016). The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis. AIDS Research and Human Retroviruses. 32(9). 868–871. 9 indexed citations

16.

Tavakkoli, Mohammad, Stephen J. Ferrando, Judith G. Rabkin, Kristen Marks, & Andrew H. Talal. (2013). Depression and Fatigue in Chronic Hepatitis C Patients With and Without HIV Co-Infection. Psychosomatics. 54(5). 466–471. 10 indexed citations

17.

Fierer, Daniel S., Douglas T. Dieterich, M. Isabel Fiel, et al.. (2012). Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-Infected Men After Primary Hepatitis C Virus Infection. Clinical Infectious Diseases. 56(7). 1038–1043. 46 indexed citations

18.

Martinez, Anthony, Rositsa B. Dimova, Kristen Marks, et al.. (2010). Integrated internist – addiction medicine – hepatology model for hepatitis C management for individuals on methadone maintenance. Journal of Viral Hepatitis. 19(1). 47–54. 47 indexed citations

19.

Wan, David, Kristen Marks, Rhonda K. Yantiss, & Andrew H. Talal. (2009). Autoimmune Hepatitis in the HIV-Infected Patient: A Therapeutic Dilemma. AIDS Patient Care and STDs. 23(6). 407–413. 17 indexed citations

20.

Marks, Kristen, Lydia M. Petrovic, Andrew H. Talal, et al.. (2005). Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus. The Journal of Infectious Diseases. 192(11). 1943–1949. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact